HEALTHAug 5 · 13:32 UTCSTAT NEWSElaine Chen

STAT+: Moderna launches early trial of Ebola mRNA vaccine

Moderna has launched an early trial of an Ebola mRNA vaccine. The article also mentions earnings reports from Amgen, Gilead Sciences, United Therapeutics, Novo, and Lilly.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

ModernaorganizationEbola mRNA vaccinetopicAmgenorganizationGilead SciencesorganizationUnited TherapeuticsorganizationNovoorganizationLillyorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSMay 1 · 13:33 UTC
Moderna CEO on Earnings, Flu Shots and Skin Cancer Trials
HEALTHAug 4 · 18:10 UTC
Moderna is testing its first mRNA Ebola vaccine as the Congo outbreak worsens
HEALTHMay 26 · 13:28 UTC
STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
HEALTHJun 18 · 13:28 UTC
STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
HEALTHJun 1 · 18:48 UTC
Moderna gets $50M investment for Ebola vaccine candidate
HEALTHAug 3 · 13:18 UTC
STAT+: Is there a pharma mega-merger in the making?